Setting

Asia Pacific Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity

Published: 30 Jun 2022 | Report Code: 10248557 | Pages: 129

Asia Pacific organ transplant diagnostics market will grow by 10.8% annually with a total addressable market cap of $12,042.8 million over 2022-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics. Highlighted with 31 tables and 58 figures, this 123-page report “Asia Pacific Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Country. Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Test Kits & Consumables o Kits & Assays o Consumables • Software & Services Based on Transplant, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solid Organ Transplant o Kidney o Liver o Heart o Lung o Pancreas o Kidney-Pancreas o Other Solid Organ Transplants • Stem Cell Transplant • Soft Tissue Transplant By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostics o Donor Testing o Recipient Testing • Translational Research By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Molecular Technologies o PCR o Sequencing o Other Molecular Technologies • Serology • Flow Cytometry • Other Technologies By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Transplant Centers • Reference Laboratories • Academic and Research Institutions • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Transplant and Technology over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Inc. ARUP Laboratories BAG Health Care GmbH Becton Dickinson and Company bioMérieux S.A. Bio-Rad Laboratories, Inc. CareDx, Inc. Eurofins Scientific F. Hoffmann-La Roche Ltd. Illumina, Inc. Immucor, Inc. Laboratory Corporation of America Holdings Novacyt Group Omixon Ltd. OPKO Health QIAGEN N.V. Quest Diagnostics Incorporated Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	25
2.2 Major Growth Drivers	27
2.3 Market Restraints and Challenges	33
2.4 Emerging Opportunities and Market Trends	36
2.5 Porter’s Fiver Forces Analysis	40
3 Segmentation of Asia Pacific Market by Offering	44
3.1 Market Overview by Offering	44
3.2 Instruments	46
3.3 Test Kits & Consumables	48
3.3.1 Kits & Assays	49
3.3.2 Consumables	51
3.4 Software & Services	53
4 Segmentation of Asia Pacific Market by Transplant	55
4.1 Market Overview by Transplant	55
4.2 Solid Organ Transplant	57
4.2.1 Kidney	59
4.2.2 Liver	60
4.2.3 Heart	61
4.2.4 Lung	62
4.2.5 Pancreas	63
4.2.6 Kidney-Pancreas	64
4.2.7 Other Solid Organ Transplants	65
4.3 Stem Cell Transplant	66
4.4 Soft Tissue Transplant	67
5 Segmentation of Asia Pacific Market by Application	68
5.1 Market Overview by Application	68
5.2 Diagnostics	70
5.2.1 Donor Testing	71
5.2.2 Recipient Testing	72
5.3 Translational Research	73
6 Segmentation of Asia Pacific Market by Technology	74
6.1 Market Overview by Technology	74
6.2 Molecular Technologies	76
6.2.1 PCR	78
6.2.2 Sequencing	79
6.2.3 Other Molecular Technologies	80
6.3 Serology	81
6.4 Flow Cytometry	82
6.5 Other Technologies	83
7 Segmentation of Asia Pacific Market by End User	84
7.1 Market Overview by End User	84
7.2 Hospitals and Transplant Centers	86
7.3 Reference Laboratories	87
7.4 Academic and Research Institutions	88
7.5 Other End Users	89
8 Asia-Pacific Market 2021-2031 by Country	90
8.1 Overview of Asia-Pacific Market	90
8.2 Japan	93
8.3 China	96
8.4 Australia	98
8.5 India	100
8.6 South Korea	102
8.7 Rest of APAC Region	104
9 Competitive Landscape	106
9.1 Overview of Key Vendors	106
9.2 New Product Launch, Partnership, Investment, and M&A	109
9.3 Company Profiles	110
Abbott Laboratories Inc.	110
ARUP Laboratories	112
BAG Health Care GmbH	113
Becton Dickinson and Company	114
bioMérieux S.A.	115
Bio-Rad Laboratories, Inc.	116
CareDx, Inc.	117
Eurofins Scientific	118
F. Hoffmann-La Roche Ltd.	119
Illumina, Inc.	120
Immucor, Inc.	121
Laboratory Corporation of America Holdings	122
Novacyt Group	123
Omixon Ltd.	124
OPKO Health	125
QIAGEN N.V.	126
Quest Diagnostics Incorporated	127
Thermo Fisher Scientific Inc.	128
RELATED REPORTS	129
List of Tables:

Table 1.  Snapshot of Asia Pacific Organ Transplant Diagnostics Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Economic Outlook, 2021-2023	23
Table 4. World Health Spending by Region, $ bn, 2013-2020	32
Table 5.  Main Product Trends and Market Opportunities in Asia Pacific Organ Transplant Diagnostics Market	36
Table 6. Asia Pacific Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	44
Table 7. Main Platforms and Key Vendors	47
Table 8. Asia Pacific Organ Transplant Diagnostics Market: Test Kits & Consumables by Type, 2021-2031, $ mn	48
Table 9. Main Kits & Assays and Key Vendors	50
Table 10. Main Consumables and Key Vendors	52
Table 11. Main Services and Key Vendors	54
Table 12. Asia Pacific Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	55
Table 13. Asia Pacific Organ Transplant Diagnostics Market: Solid Organ Transplant by Type, 2021-2031, $ mn	58
Table 14. Asia Pacific Organ Transplant Diagnostics Market by Application, 2021-2031, $ mn	68
Table 15. Asia Pacific Organ Transplant Diagnostics Market: Diagnostics by Type, 2021-2031, $ mn	70
Table 16. Asia Pacific Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	74
Table 17. Asia Pacific Organ Transplant Diagnostics Market: Molecular Technologies by Type, 2021-2031, $ mn	77
Table 18. Asia Pacific Organ Transplant Diagnostics Market by End User, 2021-2031, $ mn	84
Table 19. APAC Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn	91
Table 20. Japan Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	95
Table 21. Japan Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	95
Table 22. Japan Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	95
Table 23. China Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	97
Table 24. China Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	97
Table 25. China Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	97
Table 26. Australia Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	99
Table 27. Australia Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	99
Table 28. Australia Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	99
Table 29. India Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	101
Table 30. India Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	101
Table 31. India Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	101
Table 32. South Korea Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	103
Table 33. South Korea Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	103
Table 34. South Korea Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	103
Table 35. Organ Transplant Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn	105
Table 36. Abbott Laboratories Inc.: Company Snapshot	110
Table 37. Abbott Laboratories Inc.: Business Segmentation	111
Table 38. Abbott Laboratories Inc.: Product Portfolio	111
List of Figures:

Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Asia Pacific Organ Transplant Diagnostics Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	25
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Organ Transplant Diagnostics Market	27
Figure 7.  Leading Causes of Death in the World, 2019-2020, million	30
Figure 8.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	31
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060	31
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Organ Transplant Diagnostics Market	33
Figure 11. Investment Opportunity Analysis	37
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Organ Transplant Diagnostics Market	40
Figure 13. Breakdown of Asia Pacific Organ Transplant Diagnostics Market by Offering, 2021-2031, % of Revenue	45
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	45
Figure 15. Asia Pacific Organ Transplant Diagnostics Market by Offering: Instruments, 2021-2031, $ mn	46
Figure 16. Asia Pacific Organ Transplant Diagnostics Market by Offering: Test Kits & Consumables, 2021-2031, $ mn	48
Figure 17. Asia Pacific Organ Transplant Diagnostics Market by Test Kits & Consumables: Kits & Assays, 2021-2031, $ mn	49
Figure 18. Asia Pacific Organ Transplant Diagnostics Market by Test Kits & Consumables: Consumables, 2021-2031, $ mn	51
Figure 19. Asia Pacific Organ Transplant Diagnostics Market by Offering: Software & Services, 2021-2031, $ mn	53
Figure 20. Breakdown of Asia Pacific Organ Transplant Diagnostics Market by Transplant, 2021-2031, % of Sales Revenue	56
Figure 21. Asia Pacific Addressable Market Cap in 2022-2031 by Transplant, Value ($ mn) and Share (%)	56
Figure 22. Asia Pacific Organ Transplant Diagnostics Market by Transplant: Solid Organ Transplant, 2021-2031, $ mn	57
Figure 23. Asia Pacific Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney, 2021-2031, $ mn	59
Figure 24. Asia Pacific Organ Transplant Diagnostics Market by Solid Organ Transplant: Liver, 2021-2031, $ mn	60
Figure 25. Asia Pacific Organ Transplant Diagnostics Market by Solid Organ Transplant: Heart, 2021-2031, $ mn	61
Figure 26. Asia Pacific Organ Transplant Diagnostics Market by Solid Organ Transplant: Lung, 2021-2031, $ mn	62
Figure 27. Asia Pacific Organ Transplant Diagnostics Market by Solid Organ Transplant: Pancreas, 2021-2031, $ mn	63
Figure 28. Asia Pacific Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney-Pancreas, 2021-2031, $ mn	64
Figure 29. Asia Pacific Organ Transplant Diagnostics Market by Solid Organ Transplant: Other Solid Organ Transplants, 2021-2031, $ mn	65
Figure 30. Asia Pacific Organ Transplant Diagnostics Market by Transplant: Stem Cell Transplant, 2021-2031, $ mn	66
Figure 31. Asia Pacific Organ Transplant Diagnostics Market by Transplant: Soft Tissue Transplant, 2021-2031, $ mn	67
Figure 32. Breakdown of Asia Pacific Organ Transplant Diagnostics Market by Application, 2021-2031, % of Sales Revenue	69
Figure 33. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	69
Figure 34. Asia Pacific Organ Transplant Diagnostics Market by Application: Diagnostics, 2021-2031, $ mn	70
Figure 35. Asia Pacific Organ Transplant Diagnostics Market by Diagnostics: Donor Testing, 2021-2031, $ mn	71
Figure 36. Asia Pacific Organ Transplant Diagnostics Market by Diagnostics: Recipient Testing, 2021-2031, $ mn	72
Figure 37. Asia Pacific Organ Transplant Diagnostics Market by Application: Translational Research, 2021-2031, $ mn	73
Figure 38. Breakdown of Asia Pacific Organ Transplant Diagnostics Market by Technology, 2021-2031, % of Revenue	75
Figure 39. Asia Pacific Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)	75
Figure 40. Asia Pacific Organ Transplant Diagnostics Market by Technology: Molecular Technologies, 2021-2031, $ mn	76
Figure 41. Asia Pacific Organ Transplant Diagnostics Market by Molecular Technologies: PCR, 2021-2031, $ mn	78
Figure 42. Asia Pacific Organ Transplant Diagnostics Market by Molecular Technologies: Sequencing, 2021-2031, $ mn	79
Figure 43. Asia Pacific Organ Transplant Diagnostics Market by Molecular Technologies: Other Molecular Technologies, 2021-2031, $ mn	80
Figure 44. Asia Pacific Organ Transplant Diagnostics Market by Technology: Serology, 2021-2031, $ mn	81
Figure 45. Asia Pacific Organ Transplant Diagnostics Market by Technology: Flow Cytometry, 2021-2031, $ mn	82
Figure 46. Asia Pacific Organ Transplant Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn	83
Figure 47. Breakdown of Asia Pacific Organ Transplant Diagnostics Market by End User, 2021-2031, % of Revenue	85
Figure 48. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	85
Figure 49. Asia Pacific Organ Transplant Diagnostics Market by End User: Hospitals and Transplant Centers, 2021-2031, $ mn	86
Figure 50. Asia Pacific Organ Transplant Diagnostics Market by End User: Reference Laboratories, 2021-2031, $ mn	87
Figure 51. Asia Pacific Organ Transplant Diagnostics Market by End User: Academic and Research Institutions, 2021-2031, $ mn	88
Figure 52. Asia Pacific Organ Transplant Diagnostics Market by End User: Other End Users, 2021-2031, $ mn	89
Figure 53. Breakdown of APAC Organ Transplant Diagnostics Market by Country, 2021 and 2031, % of Revenue	91
Figure 54. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	92
Figure 55.  Organ Transplant Diagnostics Market in Japan, 2021-2031, $ mn	94
Figure 56.  Organ Transplant Diagnostics Market in China, 2021-2031, $ mn	96
Figure 57.  Organ Transplant Diagnostics Market in Australia, 2021-2031, $ mn	98
Figure 58.  Organ Transplant Diagnostics Market in India, 2021-2031, $ mn	100
Figure 59.  Organ Transplant Diagnostics Market in South Korea, 2021-2031, $ mn	102
Figure 60.  Organ Transplant Diagnostics Market in Rest of APAC, 2021-2031, $ mn	104
Figure 61. Growth Stage of Asia Pacific Organ Transplant Diagnostics Industry over the Forecast Period	106
Selected Key Players: 
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)